Literature DB >> 11249684

B7-1 gene-modified tumor cell vaccines.

S J Antonia1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 11249684

Source DB:  PubMed          Journal:  Curr Opin Mol Ther        ISSN： 1464-8431


× No keyword cloud information.
  4 in total

1.  Cancer immunotherapy using Listeria monocytogenes and listerial virulence factors.

Authors:  Laurence M Wood; Patrick D Guirnalda; Matthew M Seavey; Yvonne Paterson
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

2.  alpha-Galactosylceramide enhances the protective and therapeutic effects of tumor cell based vaccines for ovarian tumors.

Authors:  Youn Seok Choi; Talia Hoory; Archana Monie; Annie Wu; Denise Connolly; Chien-Fu Hung
Journal:  Vaccine       Date:  2008-09-02       Impact factor: 3.641

3.  Technical hurdles in a pilot clinical trial of combined B7-2 and GM-CSF immunogene therapy for glioblastomas and melanomas.

Authors:  Ian F Parney; Lung-Ji Chang; Maxine A Farr-Jones; Chunhai Hao; Michael Smylie; Kenneth C Petruk
Journal:  J Neurooncol       Date:  2006-04-21       Impact factor: 4.506

Review 4.  Rational approaches to immune regulation.

Authors:  Yvonne Paterson
Journal:  Immunol Res       Date:  2003       Impact factor: 4.505
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.